Thomsen Jillian B. 4
4 · NEKTAR THERAPEUTICS · Filed Dec 20, 2021
Insider Transaction Report
Form 4
Thomsen Jillian B.
VP & Chief Accounting Officer
Transactions
- Award
Common Stock
2021-12-16+21,200→ 167,681 total - Award
Stock Option
2021-12-16+37,600→ 37,600 totalExercise: $13.22Exp: 2029-12-15→ Common Stock (37,600 underlying)
Footnotes (3)
- [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. These RSUs vest over three years from the date of grant in substantially equal quarterly installments based on continued service.
- [F2]This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 6,190 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).
- [F3]This stock option vests over four years from the date of grant in equal monthly installments based on continued service.